Literature DB >> 26272207

Erratum to: Study protocol: differential effects of diet and physical activity based interventions in pregnancy on maternal and fetal outcomes: individual patient data (IPD) meta-analysis and health economic evaluation.

Anneloes E Ruifrok1,2, Ewelina Rogozinska3,4, Mireille N M van Poppel5, Girish Rayanagoudar6, Sally Kerry7, Christianne J M de Groot8, SeonAe Yeo9, Emma Molyneaux10, Ruben Barakat Carballo11, Maria Perales12, Annick Bogaerts13, Jose G Cecatti14, Fernanda Surita15, Jodie Dodd16, Julie Owens17, Nermeen El Beltagy18, Roland Devlieger19, Helena Teede20, Cheryce Harrison21, Lene Haakstad22, Garry X Shen23, Alexis Shub24, Narges Motahari25, Janette Khoury26, Serena Tonstad27, Riitta Luoto28, Tarja I Kinnunen29, Kym Guelfi30, Fabio Facchinetti31, Elisabetta Petrella32, Suzanne Phelan33, Tânia T Scudeller34, Kathrin Rauh35,36, Hans Hauner37, Kristina Renault38,39, Linda Reme Sagedal40, Ingvild Vistad41, Signe Nilssen Stafne42,43, Siv Mørkved44,45, Kjell Åsmund Salvesen46,47, Christina Vinter48, Marcia Vitolo49, Arne Astrup50, Nina Rica Wium Geiker51, Fionnuala McAuliffe52, Lucilla Poston53, Tracy Roberts54, Richard D Riley55, Arri Coomarasamy56, Khalid S Khan57,58, Ben Willem Mol59, Shakila Thangaratinam60,61.   

Abstract

Entities:  

Year:  2015        PMID: 26272207      PMCID: PMC4535827          DOI: 10.1186/s13643-015-0079-2

Source DB:  PubMed          Journal:  Syst Rev        ISSN: 2046-4053


× No keyword cloud information.

Erratum

After publication of this work [1], we noted that we inadvertently failed to include the complete list of all coauthors and that sample sizes of some of the trials listed in Table two were incorrect. The full list of authors has now been added and includes the names of all authors within the i-WIP Collaborative Network. The Authors’ contributions and competing interests section modified accordingly. We are publishing this erratum to update the author list, which is as follows: Anneloes E Ruifrok, Ewelina Rogozinska, Mireille NM van Poppel, Girish Rayanagoudar, Sally Kerry, Christianne JM de Groot, SeonAe Yeo, Emma Molyneaux, Fionnuala McAuliffe, Lucilla Poston, Tracy Roberts, Richard D Riley, Arri Coomarasamy, Khalid Khan, Ben Willem Mol, Ruben Barakat Carballo, Maria Perales, Annick Bogaerts, Jose G Cecatti, Fernanda Surita, Jodie Dodd, Julie Owens, Nermeen El Beltagy, Roland Devlieger, Helena Teede, Cheryce Harrison, Lene Haakstad, Garry X Shen, Alexis Shub, Narges Motahari, Janette Khoury, Serena Tonstad, Riitta Luoto, Tarja I Kinnunen, Kym Guelfi, Fabio Facchinetti, Elisabetta Petrella, Suzanne Phelan, Tânia T Scudeller, Kathrin Rauh, Hans Hauner, Kristina Renault, Linda Reme Sagedal, Ingvild Vistad, Signe Nilssen Stafne, Siv Mørkved, Kjell Åsmund Salvesen, Christina Vinter, Marcia Vitolo, Arne Astrup, Nina Rica Wium Geiker and Shakila Thangaratinam. The sample sizes of trials included in Table two have been corrected (Table 1). We are publishing this erratum to update these trial sample sizes, which include Dodd 2014 (n = 2212), Prevedel 2003 (n = 41), Renault 2013 (n = 425), Stafne 2012 (n = 855), Vinter 2011 (n = 360), Walsh 2012 (n = 800) and Wolff 2008 (n = 66).
Table 1

Studies with provisional support and consideration to share individual patient data

Study YearCountryStudy CharacteristicsOutcomesSample size
MaternalFetal
Althuizen 2012NetherlandsEthnically diverse , no BMI restrictions, age n.r., GA at inclusion < 14 wks, glucose status n.r., other risk factors: n.r.GWG, GDM, preterm delivery, CSbirth weight, macrosomia269
Barakat 2009SpainCaucasian, BMI restrictions n.r., age 25–35 yrs, GA at inclusion n.r. (total at least 26 wks intervention), glucose status n.r., no known pre-existing health problemsGWG, GA, preterm deliverybirth weight, LGA, SGA, AS, macrosomia (>4000g)142
Barakat 2011SpainSpanish (white), BMI restrictions n.r., age 23–38 yrs, GA at inclusion 1st prenatal visit, glucose status n.r., no known pre-existing health problemsGWG, GA CS, vaginal deliverybirth weight, AS80
Barakat 2013SpainCaucasian, no BMI restrictions, age n.r., GA at inclusion <10 wks, glucose status n.r., no known pre-existing health problemsGWG, GA, GDM, PIH, preterm deliverybirth weight, AS765
Bogaerts 2012BelgiumEthnically diverse , BMI ≥ 29 kg/m2, age n.r., GA at inclusion < 15 wks, nondiabetic, other risk factors: n.rGWG, GA, PE, PIH, GDM, IOL, CS, vaginal deliverybirth weight, AS197
Cavalcante 2009BrazilRace n.r., no morbid obesity, age restrictions n.r., GA at inclusion 16–20 wks, glucose status n.r., no known pre-existing health problemsGWG, preterm deliverybirth weight71
Clapp 1997USARace n.r., no morbid obesity, age restrictions n.r., GA at inclusion 8 wks, glucose status n.r., no known pre-existing health problemsGWGbirth weight51
Clapp 2000USARace n.r., no morbid obesity, age restrictions n.r., GA at inclusion 8 wks, glucose status n.r., no known pre-existing health problemsGWG, GAbirth weight12
Dodd 2014AustraliaRace n.r., BMI ≥ 25 kg/m2, age restrictions n.r., GA at inclusion <20 wks, nondiabetic, other risk factors: n.r.PE, PIH, GDM, IOL, CS, Preterm deliveryLGA, macrosomia (>4000g), hypoglycaemia, shoulder dystocia, admission to NICU2,212
El Beltagy 2013EgyptRace n.r., BMI: obese, age restrictions n.r., GA at inclusion: first antenatal visit, glucose status n.r., other risk factors: n.r.GWG, GDMbirth weight, macrosomia100
Grant 2013CanadaRace : predominantly non-Caucasian, BMI restrictions n.r., age >18 yrs, GA at inclusion n.r., glucose status: impaired glucose tolerance or GDM, no known pre-existing health problemsGWGbirth weight, macrosomia47
Guelinckx 2010BelgiumCaucasian, BMI ≥ 29 kg/m2, age restrictions n.r., GA at inclusion <15 wks, nondiabetic, no known pre-existing health problemsGWG, GA, PE, PIH, IOL, CSbirth weight, LGA85
Haakstad 2011NorwayRace n.r., BMI restrictions n.r., age restrictions n.r., GA at inclusion <24 wks, glucose status n.r., no known pre-existing health problemsGWG105
Hui 2006CanadaEthnically diverse, BMI restrictions n.r., age restrictions n.r., GA at inclusion <26 wks, nondiabetic, no known pre-existing health problemsGWG, GA, GDMbirth weight, LGA45
Hui 2011CanadaRace n.r., BMI restrictions n.r., age restrictions n.r., GA at inclusion 20–26 wks, nondiabetic, no known pre-existing health problemsGWG, GA, GDM, CSbirth weight, LGA224
Jackson 2010USAEthnically diverse, BMI restrictions n.r., age >18 yrs, GA at inclusion <26 wks, glucose status n.r., other risk factors: n.r.GWG321
Jeffries 2009AustraliaRace n.r., BMI restrictions none, age >18 - <45 yrs, GA at inclusion <14 wks, nondiabetic, other risk factors: n.r.GWG, PE, PIH, GDM , preterm delivery, CSbirth weight, LGA, SGA, hypoglycaemia, shoulder dystocia236
Khaledan 2010IranRace n.r., BMI restrictions n.r., age restrictions n.r., GA at inclusion 24–32 wks, no Diabetes Mellitus type 1 (DM1) with poor control, no known pre-existing health problemsGWG, GA, CSbirth weight39
Khoury 2005NorwayCaucasian, BMI 19–32 kg/m2. age 21–38 yrs, GA at inclusion 17–20 wks, nondiabetic, no known pre-existing health problemsGWG, PE, preterm deliverybirth weight, SGA, intra-uterine death290
Luoto 2011FinlandRace n.r., BMI >17 kg/m2, age >18 yrs, GA at inclusion 8–12 wks, nondiabetic, no known pre-existing health problemsGWG, GA, PE, GDMbirth weight, LGA, SGA399
Nascimento 2011BrazilRace n.r., BMI >26 kg/m2, age >18 yrs, GA at inclusion 14–24 wks, nondiabetic, no known pre-existing health problemsGWG, PIH, GDM, CSbirth weight, AS, LGA, SGA82
Ong 2009AustraliaRace n.r., obese, age restrictions n.r., GA at inclusion 18 wks, nondiabetic, other risk factors: n.r.GWG12
Oostdam 2012NetherlandsEthnically diverse, BMI ≥ 25.0 kg/m2, age > 18 yrs, GA at inclusion <20 wks, nondiabetic, no known pre-existing health problemsGWG, GDMbirth weight124
Petrella 2013ItalyEthnically diverse , BMI ≥ 25.0 kg/m2, age > 18 yrs, GA at inclusion 12 wks, nondiabetic, no known pre-existing health problemsGWG, GDM, PIH, preterm delivery63
Phelan 2011USAEthnically diverse, BMI ≥19.8-26.0 kg/m2, age >18 yrs, GA at inclusion 10–16 wks, glucose status n.r., no known pre-existing health problemsGWG, GA, PE, PIH, GDM, preterm delivery, CSbirth weight, macrosomia, birth weight <2500g401
Poston 2013United KingdomRace: n.r., BMI ≥30 kg/m2, age restrictions n.r., GA at inclusion >15+0 weeks and <17+6, , nondiabetic, no known pre-existing health problemsGA, GWG, PE, GDM, mode of deliveryBirth weight, macrosomia, still birth183
Prevedel 2003BrazilRace: n.r., BMI restrictions n.r., age restrictions n.r. (primiparous or adolescents), GA at inclusion 16–20 wks, glucose status n.a., no known pre-existing health problemsGWG, preterm deliverybirth weight, SGA41
Rauh 2013GermanyRace: n.r., BMI ≥18.5 kg/m2, age ≥18 yrs, GA at inclusion <18 wks, nondiabetic, no known pre-existing health problemsGWG, GDM, IOL, CS, preterm deliveryBirth weight LGA, SGA250
Renault 2013DenmarkRace: predominantly Caucasian, BMI ≥30 kg/m2, age >18 yrs, GA at inclusion <16 wks, nondiabetic, no known pre-existing health problemsGWG, GDM, PIH,PE,IOL, CS, preterm deliveryBirth weight, SGA, LGA, Birth weight >4000g425
Sagedal 2014NorwayRace: n.r., BMI ≥19 kg/m2, age ≥18 yrs, GA at inclusion <20 wks, nondiabetic, no known pre-existing health problemsGWG, GDM, CSLGA606
Stafne 2012NorwayWhite, no BMI restrictions, age >18 yrs, GA at inclusion 18–22 wks, nondiabetic, no known pre-existing health problemsGA, PE, PIH, GDM, CSbirth weight, AS, LGA, admission to NICU855
Vesco 2013USARace: n.r., BMI ≥30 kg/m2, age n.r., GA at inclusion <20 wks, nondiabetic, no known pre-existing health problemsGWG, GA, PE, PIH, GDM, CS, preterm deliverybirth weight, LGA, SGA, macrosomia (4000g)114
Vinter 2011DenmarkCaucasian, BMI 30–45 kg/m2, age 18–40 yrs, GA at inclusion 10–14 wks, nondiabetic, no known pre-existing health problemsGWG, PE, PIH, GDM, CSLGA, admission to NICU360
Vitolo 2011BrasilRace: n.r., BMI restrictions: none, age <35yrs, GA at inclusion 10–29 wks, nondiagetic, no known pre-existing health problemsGWG,PE, PIH, GDM, preterm birthbirth weight315
Walsh 2012IrelandRace: n.r., BMI restrictions n.r., age >18 yrs, GA at inclusion < 18 wks, nondiabetic, no known pre-existing health problemsGWG, GA, preterm delivery, IOL, CSbirth weight, macrosomia800
Wolff 2008DenmarkCaucasian, BMI ≥30 kg/m2, age >18 - <45 yrs, GA at inclusion <18 wks, nondiabetic, no known pre-existing health problemsGWG PE, PIH, GDM , CSbirth weight66
Yeo 2012USAEthnically diverse, BMI >19.8 kg/m2, no age restrictions, GA at inclusion 18 wks, nondiabetic, no known pre-existing health problemsGWG, PE, PIHbirth weight17

AS Apgar score, CS Caesarean section, GA Gestational Age, GDM Gestational diabetes mellitus, GWG Gestational weight gain, IOL Induction of labour, LGA Large for gestational age, NICU Neonatal Intensive Care Unit, n.r. not reported, PE Pre eclampsia, PIH Pregnancy Induced hypertension, RDS Respiratory Distress Syndrome, SGA Small for gestational age

Studies with provisional support and consideration to share individual patient data AS Apgar score, CS Caesarean section, GA Gestational Age, GDM Gestational diabetes mellitus, GWG Gestational weight gain, IOL Induction of labour, LGA Large for gestational age, NICU Neonatal Intensive Care Unit, n.r. not reported, PE Pre eclampsia, PIH Pregnancy Induced hypertension, RDS Respiratory Distress Syndrome, SGA Small for gestational age
  1 in total

1.  Study protocol: differential effects of diet and physical activity based interventions in pregnancy on maternal and fetal outcomes--individual patient data (IPD) meta-analysis and health economic evaluation.

Authors:  Anneloes E Ruifrok; Ewelina Rogozinska; Mireille N M van Poppel; Girish Rayanagoudar; Sally Kerry; Christianne J M de Groot; SeonAe Yeo; Emma Molyneaux; Fionnuala M McAuliffe; Lucilla Poston; Tracy Roberts; Richard D Riley; Arri Coomarasamy; Khalid Khan; Ben Willem Mol; Shakila Thangaratinam
Journal:  Syst Rev       Date:  2014-11-04
  1 in total
  1 in total

1.  Impact of maternal education on response to lifestyle interventions to reduce gestational weight gain: individual participant data meta-analysis.

Authors:  Eileen C O'Brien; Ricardo Segurado; Aisling A Geraghty; Goiuri Alberdi; Ewelina Rogozinska; Arne Astrup; Rubenomar Barakat Carballo; Annick Bogaerts; Jose Guilherme Cecatti; Arri Coomarasamy; Christianne J M de Groot; Roland Devlieger; Jodie M Dodd; Nermeen El Beltagy; Fabio Facchinetti; Nina Geiker; Kym Guelfi; Lene Haakstad; Cheryce Harrison; Hans Hauner; Dorte M Jensen; Khalid Khan; Tarja Inkeri Kinnunen; Riitta Luoto; Ben Willem Mol; Siv Mørkved; Narges Motahari-Tabari; Julie A Owens; Maria Perales; Elisabetta Petrella; Suzanne Phelan; Lucilla Poston; Kathrin Rauh; Girish Rayanagoudar; Kristina M Renault; Anneloes E Ruifrok; Linda Sagedal; Kjell Å Salvesen; Tania T Scudeller; Gary Shen; Alexis Shub; Signe N Stafne; Fernanda G Surita; Shakila Thangaratinam; Serena Tonstad; Mireille N M van Poppel; Christina Vinter; Ingvild Vistad; SeonAe Yeo; Fionnuala M McAuliffe
Journal:  BMJ Open       Date:  2019-08-01       Impact factor: 2.692

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.